Article

Online CME: Imaging Renal Cell Carcinoma With Ultrasonography, CT and MRI

This CME activity highlights the techniques, advantages, and limitations of ultrasongraphy, CT, and MRI in evaluating renal masses.

Credits: 1.25Fee: NoneExpires: May 26, 2011

This CME activity, intended for primary care physicians, urologists, nephrologists, oncologists, radiologists, and other physicians who care for patients with renal masses, dovetails with the increased use of abdominal imaging techniques for a variety of indications and the consequent more frequent detection of renal cell carcinoma.

The review will highlight the techniques, advantages, and limitations of ultrasonography, computed tomography (CT), and magnetic resonance imaging (MRI) in the evaluation of renal masses. It will also address the role of these imaging modalities in disease staging, as well as in surveillance of small masses and patients undergoing systemic therapy for advanced RCC.

Click here to access this third-party resource.

Related Videos
Shawn Kwatra, MD: Making the Connection Between Prurigo Nodularis, Atopic Dermatitis, and Itch
Will Herrington, MBBS, MD, MA: Empagliflozin Follow-up Data Informs Clinical Care for CKD
Jennifer Lai Yee, MD, PhD, MPH: Honing in on Sparsentan’s Benefit in Genetic FSGS
Highlighting Recent Therapies for Dermatologists, with James Del Rosso, DO
Ladan Zand, MD: Obinutuzumab Promising Option for Refractory, Primary FSGS
Rahul N. Khurana, MD: Phase 1 Results on Vamikibart for Uveitic Macular Edema | Image Credit: Northern California Retina Vitreous Associates
Sunir J. Garg, MD: | Image Credit: Wills Eye Hospital
James Del Rosso, DO: Discussing What’s New in the Medicine Chest for Dermatologists
© 2024 MJH Life Sciences

All rights reserved.